MFS transporter involved in the basal level of azole susceptibility (PubMed:26933209). Confers resistance to voriconazole and, to a lesser extent, to fluconazole (PubMed:26933209). Expression is up-regulated by exposure to human monocyte-derived immature dendritic cells (PubMed:21264256). Expression is increased in clinical azole-resistant isolates (PubMed:26933209). Exhibits enhanced susceptibility to voriconazole, however itraconazole susceptibility is less affected. Belongs to the major facilitator superfamily. DHA1 family. Polyamines/proton antiporter (TC 2.A.1.2.16) subfamily.